SMO and malignant pleural mesothelioma: For instance, treating medulloblastoma cell lines and primary malignant pleural mesothelioma cultures with the SMO inhibitor cyclopamine significantly inhibited GLI1 expression and in vivo xenograft growth in nude mice [136,137], suggesting the importance of SMO-dependent GLI activation in the tumorigenesis of these cancers.